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lexins are widely expressed transmembrane proteins
that mediate the effects of semaphorins. The molecular
mechanisms of plexin-mediated signal transduction
are still rather unclear. Plexin-B1 has recently been shown
to mediate activation of RhoA through a stable interaction
with the Rho guanine nucleotide exchange factors PDZ-
RhoGEF and LARG. However, it is unclear how the activity
of plexin-B1 and its downstream effectors is regulated by
its ligand Sema4D. Here, we show that plexin-B family
members stably associate with the receptor tyrosine kinase
ErbB-2. Binding of Sema4D to plexin-B1 stimulates the
P
 
intrinsic tyrosine kinase activity of ErbB-2, resulting in the
phosphorylation of both plexin-B1 and ErbB-2. A dominant-
negative form of ErbB-2 blocks Sema4D-induced RhoA
activation as well as axonal growth cone collapse in primary
hippocampal neurons. Our data indicate that ErbB-2 is an
important component of the plexin-B receptor system
and that ErbB-2–mediated phosphorylation of plexin-
B1 is critically involved in Sema4D-induced RhoA activa-
tion, which underlies cellular phenomena downstream of
plexin-B1, including axonal growth cone collapse.
 
Introduction
 
Semaphorins are a group of secreted or membrane bound
proteins, which have been shown to regulate axonal path-
finding during the development of the nervous system
(Raper, 2000; He et al., 2002; Fiore and Püschel, 2003;
Pasterkamp and Kolodkin, 2003). Their effects are mediated
by plexins, a group of transmembrane proteins. Although
originally described in the nervous system, most members of
the semaphorin–plexin signaling system are also expressed
outside the nervous system (Furuyama et al., 1996; Kameyama
et al., 1996; Maestrini et al., 1996; Ishikawa et al., 1997)
and are involved in the regulation of immune functions
(Bismuth and Boumsell, 2002; Kikutani and Kumanogoh,
2003), in invasive tumor growth (Giordano et al., 2002), or
in morphogenetic processes during vascular, lung, epidermal,
or cardiac development (Fujii et al., 2002; Goshima et al.,
2002; Klagsbrun et al., 2002; Serini et al., 2003; Toyofuku
et al., 2004). Four different families of plexins have been
identified in the mammalian system: plexin-A1–4, plexin-
B1–3, plexin-C1, and plexin-D1 (Nakamura et al., 2000;
Tamagnone and Comoglio, 2000). In addition to plexins,
various other proteins have been implicated either as receptors
for semaphorins or as components of the semaphorin recep-
tor complex (Pasterkamp and Kolodkin, 2003). The verte-
brate class 3 semaphorins, which signal via plexin-A family
members, require the assistance from neuropilins serving as
high affinity binding sites for the semaphorin (Takahashi et
al., 1999; Tamagnone et al., 1999; Rohm et al., 2000a;
Antipenko et al., 2003). In contrast, other semaphorins like
semaphorin 4D (Sema4D, also known as cluster of differen-
tiation antigen 100) or Sema7A bind with high affinity
directly to plexin-B1 and plexin-C1, respectively (Takahashi
et al., 1999; Tamagnone et al., 1999), and do not activate
neuropilins. There is evidence that semaphorins can also
act through plexin-independent mechanisms. Sema4D can
regulate lymphocyte function by binding to cluster of differ-
entiation antigen 72 (Kumanogoh et al., 2000), which may
also mediate some effects of Sema4D in the nervous system
(Moreau-Fauvarque et al., 2003). In addition, Sema4A
enhances T cell activation by interacting with Tim-2 (Ku-
manogoh et al., 2002), and recent evidence indicates that
Sema7A can interact with 
 
 
 
1-type integrins (Pasterkamp et
al., 2003).
Considerable progress has recently been made in under-
standing the signaling mechanisms used by plexin-B1. Several
small GTPases of the Rho family have been involved in
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plexin-B1–mediated signaling. Plexin-B1 can directly inter-
act with the GTP-bound form of Rac (Rohm et al., 2000b;
Vikis et al., 2000; Driessens et al., 2001). This interaction
inhibits Rac-dependent processes by sequestering the active
form of Rac (Vikis et al., 2002). In addition, plexin-B1
forms a complex with PSD-95/Dlg/ZO-1 (PDZ)–RhoGEF/
leukemia-associated RhoGEF (LARG) through its carboxyl-
terminal PDZ domain-binding motif (Aurandt et al., 2002;
Driessens et al., 2002; Hirotani et al., 2002; Perrot et al.,
2002; Swiercz et al., 2002). Binding of Sema4D to plexin-
B1 and activation of chimeric plexin-B2 stimulates PDZ-
RhoGEF/LARG activity, resulting in activation of RhoA
(Aurandt et al., 2002; Perrot et al., 2002; Swiercz et al.,
2002). Dominant-negative forms of PDZ-RhoGEF/LARG
block Sema4D-induced growth cone collapse in hippo-
campal neurons (Swiercz et al., 2002) as well as neurite re-
traction in PC12 cells (Perrot et al., 2002), thereby demon-
strating the role of RhoGEF-mediated RhoA activation in
Sema4D-induced cytoskeletal changes. It has been suggested
that Rnd1, which binds to the cytoplasmic part of plexin-
B1, can promote the interaction between plexin-B1 and
PDZ-RhoGEF (Oinuma et al., 2003). However, it remains
unclear how the activity of plexin-B1 and its downstream ef-
fectors is regulated by Sema4D. It was recently shown that
in epithelial cells, plexin-B1 associates with the scatter fac-
tor 1/hepatocyte growth factor receptor Met. Binding of
Sema4D to plexin-B1 can control the invasive growth of
these cells by stimulating the tyrosine kinase activity of Met,
which results in the tyrosine phosphorylation of both plexin-
B1 and Met (Giordano et al., 2002).
Here, we show that plexin-B family members can also in-
teract with the transmembrane tyrosine kinase ErbB-2.
Binding of Sema4D to plexin-B1 induces ErbB-2 activa-
tion, which results in the tyrosine phosphorylation of both
plexin-B1 and ErbB-2. ErbB-2–mediated phosphorylation
of plexin-B1 is required for Sema4D-induced RhoA activa-
tion as well as for plexin-B1–mediated axonal growth cone
collapse. This finding suggests that ErbB-2 is part of a sig-
naling complex that is required for plexin-B–mediated regu-
lation of cellular functions by semaphorins.
 
Results
 
Tyrphostin AG 1478 inhibits plexin-B1 tyrosine 
phosphorylation and RhoA activation in response 
to Sema4D
 
Recent evidence shows that plexin-B1 and PDZ-RhoGEF/
LARG form a stable complex that mediates Sema4D-
induced RhoA activation. However, the mechanism of
plexin-B1–mediated activation of RhoGEF proteins remains
unclear. We postulated that additional signals are involved
in plexin-B1 activation and subsequent stimulation of Rho-
GEF activity by Sema4D. Therefore, we tested a variety
of pharmacological inhibitors of common effectors like
phosphoinositide kinases, phospholipases, and protein ki-
nases for their potential ability to block plexin-B1/PDZ-
RhoGEF–dependent RhoA activation in human embryonic
kidney (HEK) 293 cells transfected with plexin-B1 and
PDZ-RhoGEF. Inhibition of phosphoinositide-3 kinase,
phospholipase C, or various protein kinases like Erk, Mek,
p38, Src, and protein kinase C had no effect on RhoA acti-
vation. However, the tyrphostin AG1478, which inhibits re-
ceptor tyrosine kinases of the ErbB family in intact cells
(Egeblad et al., 2001), almost completely blocked Sema4D-
mediated activation of RhoA at a concentration of 1 
 
 
 
M
(Fig. 1 A). Other tyrosine kinase inhibitors like the PDGF
receptor-specific tyrphostin AG1296 (Levitzki and Gazit,
1995) or K252a, which has been shown to inhibit autophos-
phorylation of various receptor tyrosine kinases like TrkA or
Met at nanomolar concentrations (Berg et al., 1992; Gior-
dano et al., 2002; Morotti et al., 2002), were without effect
(Fig. 1 A). AG1478 had no effect on the activation of RhoA
through active forms of G
 
 
 
12
 
/G
 
 
 
13
 
 and PDZ-RhoGEF (Fig.
1 B), suggesting that AG1478 does not interfere nonspecifi-
cally with RhoGEF-mediated activation of RhoA and that
an AG1478-sensitive tyrosine kinase is involved in some of
the signaling mechanisms upstream of RhoA activation
brought about by the plexin-B1/RhoGEF complex.
To substantiate the potential involvement of a tyrosine
kinase activity in Sema4D-induced RhoA activation, we
tested whether plexin-B1 or its downstream effectors PDZ-
RhoGEF/LARG become tyrosine-phosphorylated in response
to Sema4D. Cells cotransfected with vesicular stomati-
tis virus glycoprotein (VSV)-tagged plexin-B1 and FLAG-
Figure 1. Effect of receptor tyrosine kinase inhibitors on plexin-B1/
PDZ-RhoGEF–mediated Rho activation. (A) Cells transfected with 
cDNAs encoding Myc-tagged RhoA, wild-type VSV-tagged plexin-B1 
(PlxB1), and with wild-type FLAG-tagged PDZ-RhoGEF (PRG) were 
preincubated with increasing concentrations of tyrosine kinase (TK) 
inhibitors (as indicated) for 30 min. Thereafter, cells were incubated 
with medium from mock or Sema4D-transfected cells (Sema4D  / ) 
for 30 min, lysed, and the amount of activated RhoA was determined 
as described in Materials and methods. (B) HEK293 cells were 
transfected with cDNAs encoding Myc-tagged RhoA and constitutively 
active mutants of G 12 or G 3 (G 12QL and G 3QL). 48 h after 
transfection, cells were starved for 10 h, treated with different 
concentrations of AG1478 for 30 min, and the amount of active 
RhoA as well as RhoA expression were determined as described. 
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tagged versions of PDZ-RhoGEF or LARG were treated
with supernatants of cells expressing the myc-tagged extra-
cellular portion of Sema4D, and plexin-B1 or RhoGEF
proteins were subsequently immunoprecipitated. We could
not detect any tyrosine phosphorylation of precipitated
Figure 2. Sema4D induces AG1478-sensitive plexin-B1 phosphor-
ylation. (A) HEK293 cells were transfected with cDNAs encoding 
VSV-tagged plexin-B1 (VSV-plxB1) and FLAG-tagged PDZ-RhoGEF 
(FLAG-PRG) or LARG (FLAG-LARG). Cells were incubated with 
medium from mock or Sema4D-transfected cells (Sema4D  / ) for 
30 min, lysed, and plexin-B1 or RhoGEF proteins were precipitated 
(IP) as described in Materials and methods. Precipitates were immuno-
blotted with anti–P-Tyr antibodies to detect phosphorylated proteins 
and with anti-VSV or FLAG to prove equal expression. Lysates from 
transfected cells were immunoblotted with anti-VSV and anti-FLAG 
to determine expression of plexin-B1 and PDZ-RhoGEF/ LARG. 
(B) HEK293 cells were cotransfected with FLAG-tagged PDZ-RhoGEF 
and VSV-tagged plexin-B1, -B2, -B3, or -D1. 48 h after transfection, 
cells were incubated in the absence or presence of Sema4D and 
lysed, and plexins were immunoprecipitated with an anti-VSV 
antibody. Precipitates were blotted and probed with antiphosphoty-
rosine and anti-VSV antibody. (C) Cells transfected with wild-type 
VSV-tagged plexin-B1 and FLAG-tagged PDZ-RhoGEF were preincu-
bated with increasing concentrations of tyrphostin AG1478 for 30 min. 
Thereafter, cells were incubated with medium from mock ( ) or 
Sema4D ( ) transfected cells for 30 min, lysed, and the protein 
phosphorylation was determined as described.
Figure 3. Involvement of ErbB-2 in Sema4D-mediated signaling. 
(A and B) HEK293 cells were transfected with cDNAs encoding 
VSV-tagged plexin-B1 (VSV-plxB1), Myc-tagged RhoA, FLAG-tagged 
PDZ-RhoGEF (FLAG-PRG), and COOH-terminally truncated ErbB 
family members ( C-term ErbB-1–4) or an ErbB-2 mutant lacking 
the intracellular tyrosine kinase domain ( TK). Cells were treated 
with medium from Mock ( )- or Sema4D ( )-transfected cells, lysed, 
and plexin-B1 was immunoprecipitated (IP) using VSV antibody. 
(A) In a parallel experiment, the activation of RhoA was determined 
as described. Shown are Western blots of lysed or immunoprecipi-
tated samples stained with the indicated antibodies (IB). White lines 
indicate where films from two separate gels have been spliced 
together. (C) HEK293 cells were cotransfected with cDNAs encoding 
Myc-tagged RhoA (Myc-RhoA), VSV-tagged plexin-B1 (VSV-plxB1), 
and Mock or COOH-terminal deletion mutants of Met or ErbB-2. 
48 h after transfection, cells were starved, treated with or without 
Sema4D, and lysed. To visualize the amount of activated RhoA in 
cells, RhoA was precipitated and detected as described in Materials 
and methods. Lysates from transfected cells were immunoblotted 
with anti-Myc to determine expression of RhoA. The extent of 
Sema4D-induced plexin-B1 tyrosine phosphorylation in the absence 
or presence of dominant-negative ErbB-2 and Met was quantified by 
densitometric analysis of respective autoluminograms from three 
independent experiments (right). Shown are densitometric values in 
arbitrary units. 
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duced Sema4D-induced RhoA activation and plexin-B1
phosphorylation by only a minor extent (Fig. 3 C).
Although ErbB-2 is a member of the ErbB receptor tyro-
sine kinase family, no ligand has been described for it so far.
However, ErbB-2 is the preferred dimerization partner for
the other ErbB family members, ErbB-1, ErbB-3, and ErbB-4
(Karunagaran et al., 1996; Graus-Porta et al., 1997; Holbro
and Hynes, 2004), which serve as receptors for various
ligands including EGF, TGF
 
 
 
, and neuregulins (Harris et al.,
2003). To exclude any potential unspecific effects of superna-
tants derived from HEK293 cells expressing Sema4D, we
tested the effect of purified histidine (His)-tagged Sema4D
on plexin-B1 phosphorylation. Purified Sema4D induced ty-
rosine phosphorylation of plexin-B1 in a time- and dose-
dependent manner. Phosphorylation could be observed at 1
min after addition of Sema4D and reached a peak after 
 
 
 
10
min (Fig. 4 A). Cells lacking plexin-B1 expression did not re-
spond to Sema4D (Swiercz et al., 2002). In addition, direct
binding of Sema4D to cells expressing ErbB-2 was not ob-
served (unpublished data). Thus, the involvement of ErbB-2
in plexin-B1–mediated signaling appears to occur subsequent
to the binding of Sema4D to plexin-B1.
 
Sema4D activates downstream signaling of ErbB-2
 
Ligand-induced activation of heterodimerized ErbB-2 re-
sults in autophosphorylation of specific tyrosine residues on
ErbB-2 (Hazan et al., 1990; Segatto et al., 1990; Olayioye et
al., 2000). To test if ErbB-2 is phosphorylated in response to
RhoGEF proteins (Fig. 2 A). However, plexin-B1 was found
to be tyrosine phosphorylated in a Sema4D-dependent man-
ner (Fig. 2 A). As expected, only plexin-B1 but not other
plexins like plexin-B2, -B3, or -D1, which do not serve as
Sema4D receptors, was found to be tyrosine phosphorylated
in response to Sema4D (Fig. 2 B). Tyrosine phosphorylation
of plexin-B1 in response to Sema4D was completely inhib-
ited by 1 
 
 
 
M of AG1478 (Fig. 2 C).
 
ErbB-2 is involved in Sema4D-induced plexin-B1 
phosphorylation and RhoA activation
 
Based on the inhibitory effect of the ErbB receptor kinase
blocker AG1478, we tested the effect of dominant-negative
mutants of ErbB-1–4 lacking the cytoplasmic portion of
the protein (
 
 
 
C-terminal mutant) on Sema4D-induced ty-
rosine phosphorylation of plexin-B1 as well as on Sema4D-
induced RhoA activation in heterologously transfected
HEK293 cells. HEK cells express ErbB-1, ErbB-2, and Met,
whereas ErbB-3 and ErbB-4 could not be detected (see on-
line supplemental materials, available at http://www.jcb.org/
cgi/content/full/jcb.200312094/DC1). Although expression
of 
 
 
 
C-terminal mutants of ErbB-1, ErbB-3, and ErbB-4
had no effect, the expression of a COOH-terminally trun-
cated version of ErbB-2 as well as an ErbB-2 mutant lacking
the kinase domain completely blocked both Sema4D-
induced plexin-B1 tyrosine phosphorylation as well as
Sema4D-induced RhoA activation (Fig. 3, A and B). In con-
trast, a dominant-negative 
 
 
 
C-terminal mutant of Met re-
Figure 4. Sema4D induces activation of ErbB-2. 
(A) HEK cells transfected with cDNAs encoding VSV-
tagged plexin-B1 (VSV-plxB1) and FLAG-tagged PDZ-
RhoGEF (FLAG-PRG) were treated with 100 ng/ml of 
purified Sema4D for the indicated time periods. 
VSV-tagged plexin-B1 was precipitated, and protein 
phosphorylation was visualized by antiphosphotyrosine 
antibodies. The right panel shows a Coomassie blue–
stained gel with the preparation of purified Sema4D. 
(B) HEK293 cells were transfected with cDNAs encoding 
VSV-tagged plexin-B1 (VSV-plxB1) alone or together 
with FLAG-tagged PDZ-RhoGEF (FLAG-PRG). After 
48 h, cells were starved, stimulated with EGF or Sema4D 
as indicated, and lysed. Phosphorylation site-specific 
antiphosphotyrosine antibodies directed against ErbB-2 
tyrosine residues 1112, 1139, and 1248 were used to 
determine phosphorylation. (C) HEK293 cells were 
transfected as aforementioned, starved, stimulated with 
EGF or with increasing concentrations of Sema4D, 
and lysed. Specific antibodies directed against phos-
phorylated versions of Shc and Erk were used to 
visualize phosphorylation of those proteins. 
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Sema4D, we exposed HEK293 cells expressing plexin-B1
and PDZ-RhoGEF to increasing concentrations of purified
Sema4D. Cell lysates were probed with site-specific an-
tiphosphotyrosine antibodies directed against tyrosine phos-
phorylation sites on ErbB-2. Sema4D induced phosphoryla-
tion of tyrosine residues 1139 and 1248 but not of tyrosine
residues 877 (not depicted) or 1112 (Fig. 4 B). In contrast,
EGF, which can signal through an ErbB-1/ErbB-2 het-
erodimer, induced phosphorylation of tyrosines 1112, 1139,
and 1248 of ErbB-2 in the same cells. Interestingly, the rela-
tive potencies of Sema4D and EGF with regard to the in-
duction of site-specific tyrosine phosphorylation clearly
differed. Although Sema4D induced phosphorylation of
Y1248 at much lower concentrations than of Y1139, there
were no major differences in the concentrations of EGF re-
quired for phosphorylation of Y1112, Y1139, or Y1248
(Fig. 4 B). Phosphorylated tyrosine residues 1139 and 1248
of ErbB-2 have been shown to serve as binding sites for
Grb2 and Shc (Ricci et al., 1995). Shc becomes phosphory-
lated after binding to phosphorylated ErbB-2 and mediates
ErbB-2–dependent Erk activation together with Grb2 (Ra-
vichandran, 2001). Indeed, Shc was found to be tyrosine
phosphorylated after addition of Sema4D (Fig. 4 C), and
Sema4D induced activation of Erk, although with lower po-
tency than it induced Shc phosphorylation.
Expression of an ErbB-2 mutant in which tyrosine 1248
was mutated to phenylalanine (ErbB-2(Y1248P)) com-
pletely blocked Sema4D-induced phosphorylation of en-
dogenous ErbB-2 as well as of transfected ErbB-2 at tyrosine
1248 (Fig. 5 A). Consequently, ErbB-2(Y1248P) blocked
Sema4D-induced phosphorylation of Shc and also greatly
reduced Erk activation by Sema4D (unpublished data).
However, the ErbB-2(Y1248P) mutant had no effect on the
activation of RhoA produced by Sema4D (Fig. 5 A). Fur-
thermore, although the MEK1/2 inhibitor P98059 blocked
Sema4D-induced Erk activation (unpublished data), it failed
to affect plexin-B1–mediated activation of RhoA.
Although EGF induced a phosphorylation of ErbB-2 in
HEK293 cells, activation of ErbB-2 by EGF via the ErbB-1/
ErbB-2 heterodimer did not result in tyrosine phosphoryla-
tion of plexin B1 or activation of RhoA (Fig. 5 B). However,
when EGF is given together with Sema4D to cells expressing
plexin-B1, Sema4D-induced plexin-B1 phosphorylation can
be inhibited by EGF in a concentration-dependent manner
(Fig. 5 C), suggesting that ligand-bound plexin-B1 and
ErbB-1 compete for a common pool of ErbB-2.
 
Effect of Rac1 and Rnd1 on surface expression and 
tyrosine phosphorylation of plexin-B1
 
Both the active GTP-bound form of Rac as well as the small
GTPase Rnd1 have been shown to interact with the cyto-
plasmic portion of plexin-B1 and to modulate plexin-B1 sig-
naling (Vikis et al., 2000, 2002; Oinuma et al., 2003). As
described previously, active Rac increased the surface expres-
sion of plexin-B1 in cells transfected with plexin-B1 alone
(Vikis et al., 2002). However, Rac1 had no effect on sur-
face expression of plexin-B1 in cells coexpressing plexin-B1
and PDZ-RhoGEF (Fig. 6 A). In contrast, Rnd1 increased
surface expression of plexin-B1 only in cells coexpressing
plexin-B1 and PDZ-RhoGEF (Fig. 6, A and B), which is
consistent with the idea that Rnd1 promotes the interac-
tion between plexin-B1 and PDZ-RhoGEF (Oinuma et al.,
2003). We asked whether Rac1 or Rnd1 would modulate
Sema4D-induced tyrosine phosphorylation of plexin-B1.
Figure 5. Role of ErbB-2 in plexin-B1 activation. (A) HEK293 
cells were transfected with VSV-tagged plexin-B1 (VSV-plxB1), 
FLAG-tagged PDZ-RhoGEF (FLAG-PRG), and ErbB-2 or its mutant 
ErbB-2[Y1248P], which is unable to activate Shc. 48 h later, cells 
were treated with control buffer ( ) or with Sema4D ( ). Active 
RhoA was precipitated as described in Materials and methods. 
Plexin-B1 was precipitated using VSV-antibodies, and precipitates 
were analyzed after immunoblotting with antiphosphotyrosine 
antibodies. Lysates were analyzed with specific anti-ErbB-2[Y1248] 
antibody. (B and C) HEK293 cells were transfected with FLAG-PDZ-
RhoGEF (FLAG-PRG) and VSV-plexin-B1 (VSV-plxB1). 48 h after 
transfection, cells were treated either in the absence ( ) or presence 
of Sema4D or EGF ( ) alone (B), or cells were treated with Sema4D 
and EGF at the indicated concentrations together (C). Cells were 
lysed, and plexin-B1 phosphorylation was determined as described 
in Materials and methods. 
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Interestingly, both constitutively active Rac as well as Rnd1
enhanced Sema4D-induced plexin-B1 phosphorylation in
cells coexpressing plexin-B1 and PDZ-RhoGEF (Fig. 6 C).
The observed increase in tyrosine phosphorylation of plexin-
B1 in the presence of active Rac1 occurred in the absence of
any effect of Rac on the surface expression of plexin-B1. In
contrast, the increased tyrosine phosphorylation of plexin-
B1 in the presence of Rnd1 concurred with and may result
from an increased membrane localization of plexin-B1 in
cells expressing Rnd1.
 
Association of plexin B family members and ErbB-2
 
Given the functional interaction between plexin-B1 and
ErbB-2, we studied the potential association of plexin-B
family members and ErbB-2. In HEK293 cells, endogenous
ErbB-2 could be coimmunoprecipitated with heterologously
expressed plexin-B1, -B2, and -B3 but not with plexin-D1
(Fig. 7 A) or plexin-A1 (not depicted). A full-length version
of ErbB-2 as well as a mutant lacking the cytosolic part of
the protein associated with plexin-B1 in a ligand-indepen-
dent manner (Fig. 7 B), suggesting that both proteins stably
interact through their extracellular domains. Plexin-B1 was
unable to coimmunoprecipitate with ErbB-1, ErbB-3, or
ErbB-4 (unpublished data).
Because ErbB-2 harbors a COOH-terminal PDZ domain
interaction motif, we also tested if PDZ-RhoGEF is able to
interact with ErbB-2. Although, PDZ-RhoGEF coprecipi-
tated with ErbB-2, coprecipitation was dependent on the
presence of plexin-B1 and was not observed when a plexin-
B1 mutant that is unable to reach the cell surface and to in-
teract with PDZ-RhoGEF/LARG (Swiercz et al., 2002) was
used (Fig. 7 C). Thus, ErbB-2 and PDZ-RhoGEF do not
directly interact but are part of a complex in which both
proteins appear to be linked via plexin-B1.
 
ErbB-2 and Met are involved in Sema4D-induced 
axonal growth cone collapse
 
To test whether or not ErbB-2 is involved in the biological
effects of Sema4D, we studied its role in plexin-B1–medi-
ated axonal growth cone collapse in hippocampal neurons
(Swiercz et al., 2002). ErbB-2, which is widely expressed in
the central nervous system (Gerecke et al., 2001), was found
to be expressed in axonal growth cones of primary hippo-
campal neurons cultured from E17 rat embryos (Fig. 8, A
and B). Based on the finding that Sema4D induced an
autophosphorylation of ErbB-2 in HEK293 cells, we tested
if ErbB-2 underwent autophosphorylation in response to
Sema4D in axonal growth cones of hippocampal neurons.
Staining of neurons with an antibody specific for phosphor-
ylated tyrosine 1248 revealed that Sema4D-induced activa-
tion of ErbB-2 occurred mainly in the central domain of the
growth cone (Fig. 8 B). To test if Met is also expressed in ax-
Figure 6. Effect of small GTPases on 
plexin-B1 phosphorylation. (A and B) 
HEK293 cells were transfected with 
cDNAs encoding full-length VSV-tagged 
plexin-B1 (VSV-plxB1) and with FLAG-
tagged PDZ-RhoGEF (FLAG-PRG) as 
well as with Myc-tagged active mutant 
of Rac1 (Myc-Rac1GV) or FLAG-tagged 
Rnd1 (FLAG-Rnd1). 48 h after transfection, 
surface expression of plexin-B1 was 
quantified as described in Materials and 
methods. In a parallel experiment, cells 
were lysed and immunoblotted with 
indicated antibodies (IB) to test the equal 
protein expression. (C) HEK293 cells were 
transfected with cDNAs encoding full-
length VSV-tagged plexin-B1 (VSV-plxB1) 
alone or together with FLAG-tagged 
PDZ-RhoGEF (FLAG-PRG) and with 
Myc-tagged active mutant of Rac1 
(Myc-Rac1GV) or FLAG-tagged Rnd1 
(FLAG-Rnd1). Cells were treated with 
medium from Mock ( )- or Sema4D ( )-
transfected cells and lysed, and plexin 
was immunoprecipitated using VSV 
antibody-coupled Sepharose. Shown are 
Western blots of lysed or immunoprecipi-
tated samples stained with the indicated 
antibodies (IB). White lines indicate 
where films from two separate gels have 
been spliced together. To quantitate the 
amount of phosphorylated plexin-B1 
chemiluminescence of antiphosphoty-
rosine, blot was determined with a 
luminescence detection system as 
described in Materials and methods. 
Shown are the mean values from three 
independent experiments with the SEM. 
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onal growth cones and becomes activated upon exposure to
Sema4D, we stained hippocampal neurons with antibodies
recognizing Met phosphorylated at tyrosine residues 1234
and 1235. Sema4D induced phosphorylation of Met in the
entire growth cone (Fig. 8 C).
After treatment with Sema4D, the number of hippo-
campal neurons demonstrating axonal growth cones dropped
from 70% to 25% (Swiercz et al., 2002; Fig. 9 A). Sema4D-
induced axonal growth cone collapse was blocked when neu-
rons were pretreated with the ErbB family tyrosine kinase
blocker AG1478 (1 
 
 
 
M), whereas treatment with AG1296
or vehicle had no effect (Fig. 9, A and B). Sema4D-induced
growth cone collapse was also abrogated in cells pretreated
with high concentrations of the tyrosine kinase inhibitor
K252a (Fig. 9 B).
To test whether or not activation of Erk subsequent to
phosphorylation of ErbB-2 by Sema4D plays a role in the
effects of Sema4D on axonal growth cones, we tested the ef-
Figure 7. Association of plexins-B and ErbB-2. (A) 48 h after 
transfection with cDNAs encoding plexins-B1, -B2, -B3, or -D1 
(VSV-plexin-B1, -B2, -B3, -D1) together with FLAG-tagged PDZ-
RhoGEF (FLAG-PRG) HEK293 cells were lysed, VSV-tagged plexins 
were precipitated and precipitates were analyzed by immunoblotting 
using antibodies against ErbB-2. (B) HEK293 cells were transfected 
with ErbB-2 or its HA-tagged COOH-terminally truncated mutant 
(HA- C-term-ErbB-2) together with PDZ-RhoGEF (FLAG-PRG) and 
plexin-B1 (VSV-plxB1). Plexin was precipitated using anti-VSV 
antibodies and immunoprecipitates were analyzed with anti-ErbB-2 
or anti-HA antibody. (C) HEK293 cells were transfected with cDNAs 
encoding VSV-tagged plexin-B1 (VSV-plxB1) or its VSV-tagged 
mutant lacking the COOH-terminal 10 amino acids ( 10) together 
with FLAG-tagged PDZ-RhoGEF (FLAG-PRG) or its mutant lacking 
PDZ domain ( PDZ) and with wild-type ErbB-2 or its HA-tagged 
COOH-terminally truncated mutant (HA- C-term-ErbB-2). Cells 
were lysed, PDZ-RhoGEF or its mutant were immunoprecipitated 
using anti-FLAG antibodies, and precipitates were analyzed by 
immunoblotting.
Figure 8. Expression and activation of ErbB-2 and Met in growth 
cones. (A and B) Growth cones of developing hippocampal neurons 
were stained using anti–ErbB-2 antibody or anti-phospho-ErbB-
2[Y1248] (anti-pErbB-2) antibody in neurons treated with control or 
with Sema4D medium. (C) Developing hippocampal neurons were 
treated with control medium or Sema4D-containing medium 
(Sema4D medium), stained using anti-phospho-Met[Y1234,1235] 
(anti-pMet) antibody, and counterstained with phalloidin-TRITC 
(Phalloidin). 
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fect of the MEK1/2 inhibitor PD98059. Pretreatment of
cells with PD98059 failed to block Sema4D-induced axonal
growth cone collapse in hippocampal neurons (Fig. 9 B).
To test the involvement of receptor tyrosine kinases in
Sema4D-induced axonal growth cone collapse, we trans-
fected hippocampal neurons with dominant-negative mu-
tants of ErbB family members and Met lacking their cyto-
plasmic domains. The 
 
 
 
C-terminal mutants of ErbB-2 as
well as of Met did not alter basal outgrowth of neurites from
hippocampal neurons (unpublished data). However, growth
cone collapse induced by Sema4D was almost completely
abolished in neurons expressing a 
 
 
 
C-terminal mutant of
ErbB-2 (Fig. 10, A and B). In contrast, in neurons express-
ing 
 
 
 
C-terminal mutants of ErbB-1, ErbB-3, ErbB-4, or a
control plasmid, Sema4D significantly decreased the num-
ber of axons demonstrating growth cones (Fig. 10 B). Inter-
estingly, a 
 
 
 
C-terminal mutant of Met also interfered with
Sema4D-induced growth cone collapse (Fig. 10 B).
The 
 
 
 
C-terminal mutants of ErbB-2 and Met had no
effect on Sema3A-induced growth cone collapse (Fig. 10
C),  indicating that ErbB-2 and Met are not involved in
Sema3A-induced signaling and that their dominant-negative
versions did not unspecifically render growth cones refrac-
tory to collapse upon treatment with unrelated ligands.
 
Discussion
 
Plexins are transmembrane proteins mediating the effects of
semaphorins, which were originally identified as prominent
repulsive guidance factors for axonal growth cones during
neural development. There is now increasing evidence that
signaling via semaphorins and plexins is involved in the reg-
ulation of cellular functions in many other organ systems.
Several recent studies have addressed the signaling mecha-
nisms downstream of plexins. Plexin-B family members have
recently been shown to form a stable complex through their
COOH termini with the RhoGEF proteins PDZ-RhoGEF/
LARG, which mediate plexin-B1–dependent activation of
RhoA and subsequent changes of the actin cytoskeleton.
However, the mechanisms underlying the activation of
plexin-B1 remained unclear so far. Here, we show that the
tyrosine kinase ErbB-2 is critically involved in Sema4D-
induced activation of plexin-B1 and downstream signaling
processes via the small GTPase RhoA. Plexin-B family mem-
bers associate with endogenous ErbB-2, an interaction that
requires the extracellular domains of both receptors. Activa-
tion of plexin-B1 by Sema4D results in tyrosine phosphor-
ylation of plexin-B1 by ErbB-2. Inhibition of ErbB-2–
mediated tyrosine phosphorylation of plexin-B1 blocks
Sema4D-induced RhoA activation in HEK293 cells. Fi-
nally, dominant-negative forms of ErbB-2 block Sema4D-
induced activation of RhoA in HEK293 cells as well as
Sema4D-induced collapse of axonal growth cones in pri-
mary hippocampal neurons.
Plexin-B1 has previously been shown to associate with an
unidentified tyrosine kinase activity, which can phosphory-
late plexin-B1 in vitro (Tamagnone et al., 1999). Genetic
data indicate that the 
 
Drosophila melanogaster 
 
protein off-
track (OTK), which is structurally related to receptor
kinases, can functionally interact with 
 
D. melanogaster
 
plexin-A. Biochemical analysis suggests that OTK coimmu-
noprecipitates with mammalian plexins including plexin-B1
(Winberg et al., 2001). The functional significance of these
findings is not clear because OTK and its mammalian ortho-
logues are unlikely to be enzymatically active (Mossie et al.,
1995; Park et al., 1996). More recent studies have shown
that the receptor tyrosine kinase Met associates with plexin-
B1. Binding of Sema4D to plexin-B1 stimulates the intrinsic
tyrosine kinase activity of Met, resulting in the phosphoryla-
tion of both receptors and the Met substrate Gab1 (Gior-
dano et al., 2002). Although this paper implicates Met in
Sema4D-induced effects on epithelial cell invasive growth, it
remained unknown whether or not Met is required for the
Sema4D-induced activation of Rho via the plexin-B1/Rho-
GEF complex.
Our data indicate that after activation, plexin-B1 can also
functionally interact with ErbB-2 and that ErbB-2–mediated
phosphorylation of plexin-B1 is required for signaling of
Figure 9. Effect of various kinase inhibitors on Sema4D-induced 
growth cone collapse. (A and B) Developing neurons were treated 
with the indicated concentrations of AG1296, AG1478, K252a, or 
PD98059. Neurons were visualized using phalloidin-TRITC staining. 
Shown are examples of the effects of AG1296 and AG1248 on 
Sema4D-induced growth cone collapse (A). Insets show a magnified 
view of growth cones (indicated by arrows). (B) Shown are the mean 
values from three independent experiments with the SEM. *, P   0.05, 
ANOVA followed by post-hoc Scheffe’s test. 
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plexin-B1 via RhoGEF proteins. Sema4D-induced tyrosine
phosphorylation of plexin-B1 and subsequent RhoA activa-
tion were only slightly reduced in the presence of a
dominant-negative form of Met. In addition, the Met tyro-
sine kinase inhibitor K252a had no effect on plexin-B1
phosphorylation in response to Sema4D, indicating that Met
is not necessarily required for plexin-B1 activation. In con-
trast, phosphorylation of plexin-B1 and Sema4D-induced
RhoA activation were highly sensitive to the ErbB-specific ty-
rosine kinase inhibitor AG1478 and to dominant-negative
ErbB-2, thereby suggesting that the tyrosine kinase activity
of ErbB-2 is involved in ligand-dependent plexin-B1 phos-
phorylation. This finding is consistent with our finding
that plexin-B family members and ErbB-2 can specifically
associate.
ErbB-2 is unique among the ErbB family members as it
has no known ligand and can be activated only in trans by
ErbB-1, ErbB-3, and ErbB-4 or other tyrosine kinases like
Jak2 (Olayioye et al., 2000; Yamauchi et al., 2000; Yarden
and Sliwkowski, 2001). Recent structural data show that the
extracellular portion of ErbB-2 exists in an extended config-
uration that very likely interferes with ligand binding
(Burgess et al., 2003). Therefore, it appears unlikely that
Sema4D can directly act on ErbB-2. Consistent with this,
we did not observe any direct binding of Sema4D to ErbB-2,
nor did we see an activation of ErbB-2 in the absence of
plexin-B1. This observation indicates that Sema4D activates
ErbB-2 indirectly through plexin-B1. However, the mecha-
nisms through which Sema4D-bound plexin-B1 activates
ErbB-2, and in turn becomes phosphorylated, is still not
clear. An involvement of other ErbB family members ap-
pears unlikely because dominant-negative mutants of ErbB-1,
ErbB-3, or ErbB-4 have no effect on Sema4D-induced
activation of plexin-B1. Given that ErbB-2 and plexin-B1
associate even in the absence of ligands, it is conceivable that
Sema4D-induced clustering of plexin-B1 results in the for-
mation of plexin-B1/ErbB-2 heterooligomers, which then
allow ErbB-2 to dimerize and to become activated.
Sema4D-induced activation of ErbB-2 kinase activity also
results in the autophosphorylation of ErbB-2. Interestingly,
the pattern of ErbB-2 tyrosine residues phosphorylated in re-
sponse to Sema4D was different from that induced by EGF.
In contrast to EGF, Sema4D did not induce phosphorylation
of tyrosine residue 1112, which has been shown to provide a
docking side for the ubiquitin ligase c-Cbl (Klapper et al.,
2000). Binding of c-Cbl to ErbB-2 enhances ubiquitination
and degradation of ErbB-2 (Klapper et al., 2000; Levkowitz
et al., 2000). Therefore, lack of phosphorylation of ErbB-2 at
Figure 10. Role of ErbB-2 and Met in plexin-
B1–mediated growth cone collapse. (A) Devel-
oping hippocampal neurons were transfected 
with HA-tagged wild-type ErbB-2 (HA-ErbB-2) 
or with an HA-tagged, COOH-terminally 
truncated mutant of ErbB-2 (HA- C-ErbB-2) 
and treated with Sema4D-containing medium 
(Sema4D medium) or control medium followed 
by immunostaining with anti-HA antibody 
(anti-HA) and counterstaining with phalloidin-
TRITC. Insets show a magnified view of growth 
cones (arrowheads). (B). Developing hippo-
campal neurons were GFP transfected or trans-
fected with wild-type (ErbB-2 and Met), HA-
tagged COOH-terminally truncated ( C-Met 
and  C-ErbB-1, -2, -3, and -4), or HA-tagged ki-
nase-dead mutants ( TK ErbB-2) of various re-
ceptor tyrosine kinases and scored for growth 
cone collapse after treatment with control me-
dium (black bars) or Sema4D-containing me-
dium (gray bars). Transfected neurons were 
identified by immunocytochemistry using 
anti-HA antibody. Shown are the mean values 
from three independent experiments with the 
SEM. (C) Mock-transfected hippocampal
neurons and hippocampal neurons
transfected with dominant-negative ErbB-2 
or Met ( C-ErbB-2 and  C-Met) were treated 
with Sema3A-containing medium (white bars) 
or control medium (black bar), and growth 
cones of neurons were counted as aforemen-
tioned. *, P   0.05, ANOVA followed by
post-hoc Scheffe’s test. 
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tyrosine 1112 in response to Sema4D may reduce the pro-
pensity of ErbB-2 to become degradated after activation. In
addition, Sema4D-induced phosphorylation of tyrosine 1139
occurred with much lower potency than phosphorylation of
tyrosine 1248, whereas EGF-induced phosphorylation of
both tyrosine residues occurred with very similar potency.
These differences between EGF and Sema4D with regard to
the phosphorylation of ErbB-2 support the view that both
stimuli use different mechanisms and probably also different
kinases for ErbB-2 phosphorylation.
Sema4D-induced phosphorylation of tyrosine 1248 and
tyrosine 1139, which recruit Shc and Grb2, resulted in the
activation of the Erk pathway. However, inhibition of
Sema4D-induced Shc phosphorylation and Erk activation
using an ErbB-2 mutant lacking tyrosine 1248 or by inhibi-
tion of MEK1/2 did not affect Sema4D-induced plexin-B1
phosphorylation and subsequent RhoA activation. This re-
sult indicates that phosphorylation of ErbB-2 and activation
of downstream signaling pathways is not required for plexin-
B1–mediated activation of RhoA. Consistent with this find-
ing, EGF-induced ErbB-2 phosphorylation and activation
did not result in plexin-B1 phosphorylation and RhoA
activation. However, we observed that EGF can inhibit
Sema4D-induced plexin-B1 phosphorylation in a concen-
tration-dependent manner. This inhibition is most likely
due to the ability of EGF to sequester ErbB-2, making it un-
available to support Sema4D-induced plexin-B1 activation.
This finding indicates that plexin-B1 and the EGF receptor
ErbB-1 interact with the same pool of ErbB-2 and that also
other factors that use ErbB-2–mediated signaling pathways
may interfere with plexin-B1 activation by Sema4D.
The small GTPases Rac and Rnd1 have been shown to in-
teract with the cytoplasmic portion of plexin-B1 and to en-
hance plexin-B1–mediated signaling (Vikis et al., 2002; Oi-
numa et al., 2003). Constitutively active Rac is able to
increase the surface localization of plexin-B1 in a heterolo-
gous expression system as well as to increase its affinity for
Sema4D (Vikis et al., 2002). However, active Rac had no ef-
fect on plexin-B1 surface expression in HEK293 cells coex-
pressing plexin-B1 and PDZ-RhoGEF (Fig. 6). In contrast,
Rnd1 increased surface expression of plexin-B1 in cells coex-
pressing plexin-B1 and PDZ-RhoGEF, which is consistent
with the idea that Rnd1 promotes the interaction of plexin-
B1 and PDZ-RhoGEF (Oinuma et al., 2003). We found
that Rnd1 and active Rac also increase Sema4D-induced ty-
rosine phosphorylation of plexin-B1. Rac-induced increase
in tyrosine phosphorylation of plexin-B1 appeared to be
stronger than the effect of Rac on surface expression of
plexin-B1. This observation suggests that binding of active
Rac promotes plexin-B1 activation by increasing the affinity
for Sema4D (Vikis et al., 2002) or by other mechanisms that
facilitate ligand-induced phosphorylation of plexin-B1. Our
data support the view that active Rac is able to modulate
plexin-B1–mediated signaling.
The observation that Sema4D is able to indirectly activate
ErbB-2 and to induce Erk activation raises the interesting
possibility that signaling pathways downstream of ErbB-2
mediate some of the biological effects exerted by Sema4D
and other potential ligands for plexin-B family members.
Besides its role in tumor progression (Holbro et al., 2003),
ErbB-2 has been shown to play an important role in various
morphogenetic processes during development (Citri et al.,
2003). Interestingly, several human fetal tissues like brain,
lung, liver, and kidney have been shown to express ErbB-2
as well as plexin-B1 (Coussens et al., 1985; Maestrini et al.,
1996). Based on the ability of plexin-B1 to mediate ErbB-2
activation, it will be interesting to explore the potential role
of a functional interaction between plexin-B1 and ErbB-2
in tumor progression as well as in various developmental
processes.
Recently, the receptor tyrosine kinase Met has been impli-
cated in plexin-B1 signaling. Our data indicate that the rela-
tive contribution of Met to plexin-B1–mediated effects may
be cell specific. For example, in HEK293 cells, Sema4D-
induced plexin-B1/RhoGEF activation does not necessarily
require Met, whereas ErbB-2 is strictly essential. However,
in developing primary hippocampal neurons, Sema4D-
induced axonal growth cone collapse could be blocked by
dominant-negative mutants of both ErbB-2 and Met, and
both tyrosine kinases became phosphorylated in axonal
growth cones upon exposure of neurons to Sema4D. This
finding suggests that both tyrosine kinases may be involved
in morphogenetic effects induced by Sema4D in developing
neurons, which is consistent with the finding that plexin-B1
associates with Met (Giordano et al., 2002) as well as with
ErbB-2, as shown here, and can signal through both receptor
tyrosine kinases. Although an interaction between ErbB-1
and Met has been reported (Jo et al., 2000), a direct interac-
tion between Met and ErbB-2 has not been described yet.
Although we have been unable to coimmunoprecipitate
both proteins in HEK293 cells, one cannot rule out the pos-
sibility that Met and ErbB-2 exist in a heterooligomeric
complex with plexin-B1.
In summary, we show that plexin-B family members asso-
ciate with ErbB-2 and that Sema4D is able to activate ErbB-2
indirectly via plexin-B1. Sema4D may exert some of its
activities by downstream signaling of ErbB-2. However,
plexin-B1/RhoGEF–mediated activation of RhoA only re-
quires phosphorylation of plexin-B1 by ErbB-2. These re-
sults provide novel insight into signaling pathways used by
semaphorins and plexins and open new vistas for their cellu-
lar effects.
 
Materials and methods
 
Cell culture and precipitation studies
 
COS-7 and HEK293 cells were cultured as described previously (Swiercz
et al., 2002). For immunoprecipitation, HEK293 cells were collected 48 h
after transfection and lysed for 30 min in ice-cold radioimmunoprecipita-
tion buffer (1% Triton X-100, 150 mM NaCl, 50 mM Tris, pH 7.4, 0.1% so-
dium dodecyl sulfate, 0.25% Na-deoxycholate, 1 
 
 
 
g/ml of each leupeptin,
aprotinin, and pepstatin, 1 mM 4-(2-aminoethyl)-benzosulfonylfluorid-
hydrochloride, and 1 mM Na
 
3
 
VO
 
4
 
). Proteins from cell extracts were pre-
cipitated with anti-FLAG M2 mAb Agarose (Sigma-Aldrich) or anti-VSV-G
Agarose affinity gel. In other experiments, we used anti–ErbB-2 antibodies.
Antibody–antigen complexes were isolated by binding to protein A/G–Seph-
arose followed by washing with ice-cold radioimmunoprecipitation buffer.
Precipitated proteins were separated using SDS-PAGE followed by transfer
onto nitrocellulose membrane (Schleicher & Schuell) and blocking of non-
specific binding sites with 5% milk in TBST. Blots were probed with appro-
priate antibodies, and proteins were visualized using an ECL system (Amer-
sham Biosciences). In some cases, blots probed with antiphosphotyrosine
antibodies were treated with ECL reagent, and luminescence was scanned
and quantified using a Fluoro-S-Multi-Imager (Bio-Rad Laboratories). 
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Alkaline phosphatase assay
 
At 48 h after transfection with VSV-tagged plexin-B1 alone or together with
RhoGEF and/or small GTPases, COS7 cells were treated with primary anti-
VSV antibody diluted in DME (Invitrogen) containing 5% horse serum for
2 h at 4
 
 
 
C. Cells were washed, fixed with 4% PFA for 10 min, and incu-
bated with the AP-linked anti–mouse antibody. AP assay reagent A (Gene
Hunter Corporation) was used to visualize AP activity.
 
Purification of Sema4D on (6)His affinity column
 
Medium from HEK293 cells transfected with His-Sema4D in pBK-CMV
vector containing Sema3A signal peptide for secretion was collected 48 h
after transfection and purified on a HisTrap Kit following the manufac-
turer’s instructions (Amersham Biosciences).
 
Determination of activated Rho
 
The amount of activated RhoA was determined as described previously
(Swiercz et al., 2002) by precipitation with a fusion protein consisting of
GST and the Rho-binding domain of Rhotekin, as described by Ren and
Schwartz (2000).
 
Erk and Shc phosphorylation studies
 
HEK293 cells were transfected with plexin-B1 and PDZ-RhoGEF. 48 h af-
ter transfection, cells were starved for 12 h and treated for 30 min with pu-
rified Sema4D. Cells were lysed, and lysates were separated using SDS-
PAGE and transferred on nitrocellulose membrane (Schleicher & Schuell).
Phospho-Erk and phospho-Shc were detected by using specific anti–phos-
pho-Erk (Santa Cruz Biotechnology, Inc.) and anti–phospho-Shc[Y317]
(Cell Signaling Technology) antibodies.
 
Growth cone collapse, immunocytochemistry, 
and image processing
 
At 24 h after transfection, neurons were treated with medium derived from
either mock-transfected or (myc)Sema4D-transfected HEK293 cells for 1 h
at 37
 
 
 
C. Neurons were fixed with 4% PFA and used for immunocytochem-
istry experiments using fluorescently-conjugated secondary antibodies (Di-
anova). TRITC-labeled phalloidin was used to detect actin filaments in
growth cones. Neurons were scored for the presence of growth cones as
described previously (Swiercz et al., 2002). Immunoreactivity for the ex-
pressed proteins was analyzed and photographed using a laser-scanning
confocal microscope (model TCS AOBS; Leica) using the following objec-
tives: HCXPLAPO 63
 
 
 
/1.32-0.60 oil and HC PL FLUOTAR 20
 
 
 
/0.50. All
images were acquired similarly at RT with the same laser output to directly
compare the fluorescence signal intensities. Images were processed with
the confocal image analysis software package (TCS AOBS; Leica) and im-
ported as TIFF files into Adobe Illustrator
 
®
 
 10.0. In colocalization studies,
various fluorophores were scanned in the sequential mode to completely
rule out potential overlap of fluorescence spectra.
 
Online supplemental material
 
Fig. S1 shows the expression of ErbB family members and Met in HEK 293
cells. Shown are Western blots of reverse transcriptase polymerase chain
reaction. 
Details regarding the expression plasmids, antibodies, and reagents
used for this study are available at http://www.jcb.org/content/full/jcb.
200312094/DC1.
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